Mitoquinone Helps Combat the Neurological, Cognitive, and Molecular Consequences of Open Head Traumatic Brain Injury at Chronic Time Point

Traumatic brain injury (TBI) is a heterogeneous disease in its origin, neuropathology, and prognosis, with no FDA-approved treatments. The pathology of TBI is complicated and not sufficiently understood, which is the reason why more than 30 clinical trials in the past three decades turned out unsucc...

Descripción completa

Detalles Bibliográficos
Autores principales: Haidar, Muhammad Ali, Shakkour, Zaynab, Barsa, Chloe, Tabet, Maha, Mekhjian, Sarin, Darwish, Hala, Goli, Mona, Shear, Deborah, Pandya, Jignesh D., Mechref, Yehia, El Khoury, Riyad, Wang, Kevin, Kobeissy, Firas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869514/
https://www.ncbi.nlm.nih.gov/pubmed/35203460
http://dx.doi.org/10.3390/biomedicines10020250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869514/
https://www.ncbi.nlm.nih.gov/pubmed/35203460
http://dx.doi.org/10.3390/biomedicines10020250

Ejemplares similares